ABN Amro's board will not recommend either of the two rival takeover bids the Dutch bank has received, it told shareholders yesterday.
The Barclays PLC bid fits better with ABN's own corporate strategy while the one from a consortium led by Royal Bank of Scotland (RBS) PLC is worth more, but risky, ABN's board said.
Either takeover, if successful, would be the largest in the history of the financial industry. ABN Amro Holding NV shareholders meet on Thursday to discuss the rival bids, which expire on Oct. 4 and 5 respectively.
"The combination with Barclays remains consistent with the strategic intent of ABN Amro as an institution," the statement said.
"Furthermore, the ABN Amro boards are not in a position to support the break up of ABN Amro [as planned by the consortium] but acknowledge that the consortium offer ... is clearly superior for the ABN Amro shareholders from a financial point of view," it said.
At Friday's closing prices, the mostly cash bid by RBS was worth 70.2 billion euros (US$97.4 billion), or 37.91 euros per ABN share -- 19 percent more than Barclays' mostly share bid.
However, ABN shares closed at 35 euros, signaling investors still have doubts as to whether the RBS deal will prevail.
While Barclays' bid has passed all regulatory hurdles, the RBS bid awaits approval from EU competition authorities, and a statement of "no objection" from Dutch financial authorities.
In addition, amid recent turmoil on credit markets, there is some question as to whether the consortium members could run into trouble arranging financing for their deal -- even though all members have strong credit profiles and underwriting agreements are in place with prestigious financial management companies like Merrill Lynch.
Among the consortium, Fortis NV of Belgium wants ABN's Dutch operations, Banco Santander Central Hispano SA wants its Brazilian and Italian arms, and RBS wants the rest, including ABN's investment banking arm.
ABN said the amount of money the consortium still needs to raise "is high in absolute and relative terms and market circumstances are volatile at this point in time."
It hinted at the risk the consortium could lower or walk away from its offer, citing the "Material Adverse Change" clause in its offer documents, which ABN described as "broadly-worded."
ABN vowed to work with Dutch and European regulators to resolve any conditions imposed on a deal with RBS, if it is the one shareholders approve.
"Nevertheless, the ABN Amro boards continue to see additional business and operational risks" in the RBS deal, they said.
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,
The Ministry of Transportation and Communications yesterday said that it would redesign the written portion of the driver’s license exam to make it more rigorous. “We hope that the exam can assess drivers’ understanding of traffic rules, particularly those who take the driver’s license test for the first time. In the past, drivers only needed to cram a book of test questions to pass the written exam,” Minister of Transportation and Communications Chen Shih-kai (陳世凱) told a news conference at the Taoyuan Motor Vehicle Office. “In the future, they would not be able to pass the test unless they study traffic regulations
‘A SURVIVAL QUESTION’: US officials have been urging the opposition KMT and TPP not to block defense spending, especially the special defense budget, an official said The US plans to ramp up weapons sales to Taiwan to a level exceeding US President Donald Trump’s first term as part of an effort to deter China as it intensifies military pressure on the nation, two US officials said on condition of anonymity. If US arms sales do accelerate, it could ease worries about the extent of Trump’s commitment to Taiwan. It would also add new friction to the tense US-China relationship. The officials said they expect US approvals for weapons sales to Taiwan over the next four years to surpass those in Trump’s first term, with one of them saying
‘COMING MENACINGLY’: The CDC advised wearing a mask when visiting hospitals or long-term care centers, on public transportation and in crowded indoor venues Hospital visits for COVID-19 last week increased by 113 percent to 41,402, the Centers for Disease Control (CDC) said yesterday, as it encouraged people to wear a mask in three public settings to prevent infection. CDC Epidemic Intelligence Center Deputy Director Lee Chia-lin (李佳琳) said weekly hospital visits for COVID-19 have been increasing for seven consecutive weeks, and 102 severe COVID-19 cases and 19 deaths were confirmed last week, both the highest weekly numbers this year. CDC physician Lee Tsung-han (李宗翰) said the youngest person hospitalized due to the disease this year was reported last week, a one-month-old baby, who does not
RSS